Xuan Xiong

87 Xiangya Road
Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Rosmarinic acid inhibits non-small cell lung cancer progression by directly targeting KRASG12C and modulating the KRAS/AKT/ERK signaling axis.

Rosmarinic acid inhibits non-small cell lung cancer progression by directly targeting KRASG12C and modulating the KRAS/AKT/ERK signaling axis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 09, 2025

Fibronectin-assisted reactive oxygen species-responsive mesoporous silica-loaded epigallocatechin-3-gallate for treating diabetic nephropathy by enhancing autophagy and regulating M1-type macrophage polarization.

Fibronectin-assisted reactive oxygen species-responsive mesoporous silica-loaded epigallocatechin-3-gallate for treating diabetic nephropathy by enhancing autophagy and regulating M1-type macrophage polarization.

Journal: International journal of biological macromolecules

Published: March 17, 2025

Circular RNA expression profile in transgenic diabetic mouse kidneys.

Circular RNA expression profile in transgenic diabetic mouse kidneys.

Journal: Cellular & molecular biology letters

Published: March 29, 2021

AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways.

AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways.

Journal: Scientific reports

Published: April 11, 2018

Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.

Sevelamer hydrochloride suppresses proliferation of parathyroid cells during the early phase of chronic renal failure in rats.

Journal: Nephrology (Carlton, Vic.)

Published: December 19, 2017

Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy.

Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy.

Journal: Bioorganic & medicinal chemistry letters

Published: April 13, 2017

GSTA3 Attenuates Renal Interstitial Fibrosis by Inhibiting TGF-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression.

GSTA3 Attenuates Renal Interstitial Fibrosis by Inhibiting TGF-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression.

Journal: PloS one

Published: April 06, 2016

Comparison of Intradialytic Parenteral Nutrition with Glucose or Amino Acid Mixtures in Maintenance Hemodialysis Patients.

Comparison of Intradialytic Parenteral Nutrition with Glucose or Amino Acid Mixtures in Maintenance Hemodialysis Patients.

Journal: Nutrients

Published: January 12, 2016

Association between MTHFR C677T polymorphism and diabetic nephropathy in the Chinese population: An updated meta-analysis and review.

Association between MTHFR C677T polymorphism and diabetic nephropathy in the Chinese population: An updated meta-analysis and review.

Journal: Nephrology (Carlton, Vic.)

Published: June 09, 2015

Fluorofenidone offers improved renoprotection at early interventions during the course of diabetic nephropathy in db/db mice via multiple pathways.

Fluorofenidone offers improved renoprotection at early interventions during the course of diabetic nephropathy in db/db mice via multiple pathways.

Journal: PloS one

Published: December 31, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026